Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Journal for Immunotherapy of Cancer|September 26, 2022
Loss of secreted gelsolin enhances response to anticancer therapiesKok Haw Jonathan Lim, Evangelos Giampazolias, Oliver Schulz, et al.Frontiers in Immunology|November 4, 2021
Kickstarting Immunity in Cold Tumours: Localised Tumour Therapy Combinations With Immune Checkpoint BlockadeElizabeth Appleton, Jehanne Hassan, Charleen Chan Wah Hak, et al.Clinical and Translational Radiation Oncology|June 22, 2018
Methodology for tissue sample collection within a translational sub-study of the CHHiP trial (CRUK/06/016), a large randomised phase III trial in localised prostate cancerAnna Wilkins, Christine Stuttle, Shama Hassan, et al.Scientific Reports|March 30, 2021
TP53 modulates radiotherapy fraction size sensitivity in normal and malignant cellsSelvakumar Anbalagan, Cecilia Ström, Jessica A Downs, et al.BJU International|July 18, 2023
International Society of Urological Pathology (ISUP) Gleason Grade Groups stratify outcomes in the CHHiP Phase 3 prostate radiotherapy trialDavid Dearnaley, Clare L Griffin, Pedro Silva, et al.Life Science Alliance|January 28, 2021
A FIJI macro for quantifying pattern in extracellular matrixEsther Wershof, Danielle Park, David J Barry, et al.Journal of the American Chemical Society|June 6, 2003
Rational design of a calcium-binding proteinWei Yang, Lisa M Jones, Leanne Isley, et al.International Journal of Radiation Oncology, Biology, Physics|August 19, 2022
The Fraction Size Sensitivity of Late Genitourinary Toxicity: Analysis of Alpha/Beta (α/β) Ratios in the CHHiP TrialDouglas H Brand, Sarah C Brüningk, Anna Wilkins, et al.International Journal of Radiation Oncology, Biology, Physics|July 11, 2023
Gastrointestinal Toxicity Prediction Not Influenced by Rectal Contour or Dose-Volume Histogram DefinitionDouglas H Brand, Sarah C Brüningk, Anna Wilkins, et al.International Journal of Radiation Oncology, Biology, Physics|January 7, 2021
Estimates of Alpha/Beta (α/β) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP TrialDouglas H Brand, Sarah C Brüningk, Anna Wilkins, et al.Pageof 5